2025-07-11 - Analysis Report
Okay, here's a report summarizing the provided data for Merck & Co Inc (MRK), including key figures, analysis, and recent news.

## Merck & Co Inc (MRK) Stock Analysis

**Ticker:** MRK
**Company:** Merck & Co Inc
**Description:** A global pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of a wide range of healthcare products.

### 1. Performance vs. S&P 500 (VOO)

*   **MRK Cumulative Return:** 0.75%
*   **VOO Cumulative Return:** 96.17%
*   **Relative Performance Deviation:**
    *   Max: 23.1
    *   Min: -99.5
    *   Current: -94.4
    *   Relative Deviation Position: 4.2

**Analysis:** MRK has significantly underperformed the S&P 500 (VOO) over the analyzed period, with a substantial negative deviation. The relative deviation position of 4.2 suggests that MRK's underperformance is near its historical worst compared to VOO.

**Alpha, Beta Analysis:**

| Year      | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :---------- | :------ | :------ | :------ | :---- | :------ |
| 2015-2017 | 5.0%    | 58.2%   | -24.0%  | -0.0  | 134.8  |
| 2016-2018 | 43.0%   | 66.4%   | 25.0%   | -0.1  | 183.1  |
| 2017-2019 | 40.0%   | 66.4%   | 11.0%   | 0.3   | 217.9  |
| 2018-2020 | 20.0%   | 66.4%   | 0.0%    | 0.3   | 196.0  |
| 2019-2021 | -1.0%   | 65.6%   | -50.0%  | 0.3   | 192.4  |
| 2020-2022 | 13.0%   | 69.5%   | 11.0%   | 0.3   | 278.6  |
| 2021-2023 | 31.0%   | 69.5%   | 13.0%   | 0.3   | 273.8  |
| 2022-2024 | -7.0%   | 69.5%   | -33.0%  | 0.2   | 249.8  |
| 2023-2025 | -51.0%  | 61.4%   | -99.0%  | 0.5   | 211.0  |

**Analysis:**

*   **CAGR:** Fluctuates significantly, with recent years showing substantial negative growth.
*   **MDD:** Consistently high Maximum Drawdown values, indicating significant volatility.
*   **Alpha:** Mostly negative, especially in recent periods, suggesting underperformance relative to the benchmark.
*   **Beta:** Generally low, indicating lower sensitivity to market movements.  The recent increase to 0.5 suggests a slightly stronger correlation with the market recently.
*   **Capitalization:** Decreasing recently, reflecting market valuation changes.

### 2. Recent Stock Price Movement

*   **Current Price:** 84.02
*   **Previous Close:** 83.71
*   **Change:** 0.37
*   **5-Day Moving Average:** 82.68
*   **20-Day Moving Average:** 80.814
*   **60-Day Moving Average:** 79.4253

**Analysis:** The stock price is currently above its 5, 20, and 60-day moving averages, suggesting a short-term upward trend. The small price change from the previous close suggests that recent price movement isn't particularly volatile.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3373 (Low Risk)
*   **RSI:** 70.73 (Overbought)
*   **PPO:** 0.53
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.33)
*   **Delta Previous Relative Divergence:** 4.2 (Positive - Short-term increase)
*   **Expected Return (%):** -242.1% (Long-term underperformance vs. S&P 500)

**Analysis:**

*   The **Market Risk Indicator (MRI)** suggests low market risk.
*   The **RSI** is above 70, indicating that the stock is currently overbought and may be due for a correction.
*   The **PPO** is positive, supporting the upward trend indicated by the moving averages.
*   The **Hybrid Signal** suggests a partial buy signal (80% of available cash), but advises caution due to the broader market risk.
*   The **positive change in Relative Divergence** indicates short-term positive momentum compared to the S&P 500.
*   The **expected return** is extremely negative, suggesting significant long-term underperformance compared to the S&P 500 if investing at the current time.

### 4. Recent News & Significant Events

*   **[2025-07-09]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-10]:** Analyst discussions regarding performance in the context of industry trends and global economic factors.
*   **[2025-07-11]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-07]:** Market experts highlight both risks and opportunities, advising investors to monitor news.

**Analysis:** Recent news suggests potential volatility and significant events impacting Merck. Investors should monitor news releases and company announcements closely.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
| :---------- | :---- | :---------- |
| 2025-05-02 | 2.01 | 15.53 B$   |
| 2024-11-06 | 1.25 | 16.66 B$   |
| 2024-08-05 | 2.15 | 16.11 B$   |
| 2024-05-03 | 1.88 | 15.78 B$   |
| 2025-05-02 | 1.88 | 15.78 B$   |

**Analysis:**  Earnings per share (EPS) and revenue have fluctuated over the last few quarters. Revenue has been relatively stable, while EPS has shown more variability. It appears there is a duplicate date for '2025-05-02' which skews the analysis.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :------------ |
| 2025-03-31 | $15.53B  | 77.98%        |
| 2024-12-31 | $15.62B  | 75.50%        |
| 2024-09-30 | $16.66B  | 75.51%        |
| 2024-06-30 | $16.11B  | 76.76%        |
| 2024-03-31 | $15.78B  | 77.56%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
| :--------- | :-------- | :------- |
| 2025-03-31 | $48.34B  | 10.51%  |
| 2024-12-31 | $46.31B  | 8.08%   |
| 2024-09-30 | $44.50B  | 7.09%   |
| 2024-06-30 | $43.58B  | 12.52%  |
| 2024-03-31 | $40.36B  | 11.80%  |

**Analysis:**

*   **Revenue:**  Relatively stable over the past five quarters, with a slight peak in 2024-09-30.
*   **Profit Margin:** Strong and consistent, indicating good profitability.
*   **Equity:** Growing steadily, showing positive capital accumulation.
*   **ROE:** Fluctuates, reflecting changes in profitability relative to equity. Recent ROE has decreased.

### 7. Overall Summary

Merck & Co Inc (MRK) presents a mixed picture. While the company maintains strong profitability and a low market risk indicator, it has significantly underperformed the S&P 500, with negative expected returns. Recent news suggests potential volatility and significant events impacting the stock. Short-term technical indicators suggest an overbought condition. Investors should be cautious and closely monitor company news and financial reports. The long-term outlook, based on the provided data, is not promising without significant positive changes in performance and market sentiment.
